Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 11 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Turcot syndrome 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdoid Tumor 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Patient Outcome Assessment 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Locally Advanced Malignant Neoplasm 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hypopharyngeal Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Gemcitabine 406 Oxaliplatin 131 Fluorouracil 125 130-nm albumin-bound paclitaxel 108 Capecitabine 100 Albumin-Bound Paclitaxel 90 Leucovorin 88 Irinotecan 87 Radiotherapy 76 Radiosurgery 64 Taxes 63 Cisplatin 56 Erlotinib Hydrochloride 44 Drug Therapy 42 folfirinox 40 Magnetic Resonance Spectroscopy 39 pembrolizumab 35 Blood Specimen Collection 33 S 1 (combination) 31 Pancreaticoduodenectomy 31 Docetaxel 31 Nivolumab 30 Bevacizumab 30 Biopsy 26 Surgical Procedures, Operative 25 Cyclophosphamide 25 irinotecan sucrosofate 24 Specimen Handling 24 Radiation 22 Standard of Care 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Neoplasms × Induction Chemotherapy × Clear all

NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡